Ulla Hansen

5PUBLICATIONS
9CO-AUTHORS
Molecular targetsCheminformatics and quantitative structure-activity relationshipsMicro-manipulationPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Dec 18, 2025
Preclinical Lead Optimization of Small Molecule Inhibitors of TFCP2 (LSF) for the Treatment of Liver Cancer.

Niranjana Pokharel, Daniel Nartey, Emily York

|Jun 15, 2022
Factor quinolinone inhibitors disrupt spindles and multiple LSF (TFCP2)-protein interactions in mitosis, including with microtubule-associated proteins.

Sarah A Yunes, Jennifer L S Willoughby, Julian H Kwan

|Jun 17, 2020
Targeting the oncogene LSF with either the small molecule inhibitor FQI1 or siRNA causes mitotic delays with unaligned chromosomes, resulting in cell death or senescence.

Jennifer L S Willoughby, Kelly George, Mark P Roberto

|Mar 01, 2020
The microtubule-associated histone methyltransferase SET8, facilitated by transcription factor LSF, methylates α-tubulin.

Hang Gyeong Chin, Pierre-Olivier Esteve, Cristian Ruse

|Feb 27, 2020
Expansile Nanoparticles Encapsulate Factor Quinolinone Inhibitor 1 and Accumulate in Murine Liver upon Intravenous Administration.

Patrick Stoiber, Iriny Ekladious, Qing Zhao

Pageof 1

Frequent Collaborators

3 joint publications

Scott E Schaus

1 joint publications

Patrick Stoiber

1 joint publications

Iriny Ekladious

1 joint publications

Qing Zhao